Phreesia (NYSE:PHR) Shares Gap Up – What’s Next?

Phreesia, Inc. (NYSE:PHR)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $26.98, but opened at $27.67. Phreesia shares last traded at $27.30, with a volume of 42,629 shares trading hands.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Truist Financial raised their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Robert W. Baird dropped their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a report on Wednesday. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Finally, Needham & Company LLC restated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Eleven analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $30.18.

Phreesia Stock Performance

The company has a market capitalization of $1.60 billion, a PE ratio of -18.77 and a beta of 0.94. The firm has a 50-day moving average of $22.30 and a two-hundred day moving average of $22.49. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business’s revenue was up 16.6% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.58) EPS. Research analysts anticipate that Phreesia, Inc. will post -1.16 EPS for the current year.

Insider Transactions at Phreesia

In other news, General Counsel Allison C. Hoffman sold 3,495 shares of the stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $24.88, for a total transaction of $86,955.60. Following the transaction, the general counsel now owns 116,296 shares in the company, valued at $2,893,444.48. This trade represents a 2.92 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Amy Beth Vanduyn sold 25,447 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71. Following the completion of the sale, the senior vice president now directly owns 93,470 shares of the company’s stock, valued at approximately $1,956,327.10. The trade was a 21.40 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 90,342 shares of company stock valued at $2,041,225 in the last ninety days. 5.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Phreesia

Several large investors have recently made changes to their positions in the company. International Assets Investment Management LLC increased its stake in shares of Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after acquiring an additional 1,395 shares during the last quarter. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Phreesia in the second quarter valued at $202,000. Point72 DIFC Ltd acquired a new position in Phreesia in the 2nd quarter valued at about $209,000. XTX Topco Ltd purchased a new position in Phreesia in the 3rd quarter valued at approximately $247,000. Finally, Hsbc Holdings PLC purchased a new position in Phreesia in the second quarter valued at $301,000. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.